Mysimba® Dosing Information


Tablets should be swallowed whole with some water
Tablets should preferably be taken with food
Tablets should not be cut, chewed, or crushed


The dose should be escalated over a 4 week period as follows, or as advised by your doctor.


Mysimba® SPC available at

IE-MYS-140a   |  Date of preparation: December 2020

Mysimba®is subject to additional monitoring. To report an adverse event or a product complaint about Mysimba®, please contact: HPRA Pharmacovigilance, Earlsfort Terrace, IRL – Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517; Website:; e-mail: Adverse events should also be reported to Nalpropion Pharmaceuticals LLC: (800) 793-2145 or

For all other queries, please contact our Irish office at Tel: +353 (0)1 2057760, Fax: +353 (0)1 2698919 or

Copyright ©2017 Consilient Health. All rights reserved.

The information on this website is intended for healthcare professionals registered in the Republic of Ireland only.

Mysimba® is a registered trademark of Nalpropion Pharmaceuticals LLC

© 2020 Nalpropion Pharmaceuticals LLC

Other trademarks, registered or otherwise, are the property of their respective owners.